Evaluation of EGFR mutation status in cytology specimens: An institutional experience

Diagnostic Cytopathology

Volumn 41, Issue 4, 2013, Pages 316-323

  Aisner, D L ^a   Deshpande, C ^b   Baloch, Z ^b   Watt, C D ^b   Litzky, L A ^b   Malhotra, B ^c   Sepulveda, A R ^b   Langer, C ^b   Evans, T ^b   Van Deerlin, V M ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

adequacy; cell block; EGFR; molecular; mutation

Indexed keywords

CELL DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; DNA; EGFR PROTEIN, HUMAN;

ADULT; AGED; CANCER TISSUE; CELL AGGREGATION; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TUMOR VOLUME; CARCINOMA, NON-SMALL-CELL LUNG; FINE NEEDLE ASPIRATION BIOPSY; GENETICS; MIDDLE AGED; MUTATION; MUTATION RATE; NUCLEOTIDE SEQUENCE; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTATION RATE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84876459238     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21851     Document Type: Review

References (31)

1. WHO Fact Sheet 297.www.who.org; a. WHO Fact Sheet 297. Accessed on April 20, 2011.
2. SEER Fast Facts. http://seer.cancer.gov; ao.Accessed on April 20, 2011.
3. da Cunha Santos G, Shepherd FA, Tsao MS,. EGFR mutations and lung cancer. Annu Rev Pathol 2011; 6: 49-69.
4. Kotsakis A, Georgoulias V,. Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer. Expert Opin Pharmacother 2010; 11: 2363-2389.
5. Gazdar AF,. Personalized medicine and inhibition of EGFR signaling in lung cancer. N Engl J Med 2009; 361: 1018-1020.
6. Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009; 361: 947-957.
7. Ettinger DS, Akerley W, Bepler G, et al. Non-small cell lung cancer. JNCCN 2010; 8: 740-801.
8. Hirsch FR, Bunn PA, Jr,. EGFR testing in lung cancer is ready for prime time. Lancet Oncol 2009; 10: 432-433.
9. Travis WD, Rekhtman N, Riley GJ, et al. Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: A paradigm shift. J Thorac 2010; 5: 411-414.
10. Malapelle U, Bellevicine C, Zeppa P, Palombini L, Troncone G,. Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy: A review. Diagn Cytopathol 2011; 39: 703-710.
11. Pan Q, Pao W, Ladanyi M,. Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas. J Mol Diagn 2005; 7: 396-403.
12. Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010; 362: 2380-2388.
13. Boldrini L, Gisfredi S, Ursino S, et al. Mutational analysis in cytological specimens of advanced lung adenocarcinoma: A sensitive method for molecular diagnosis. J Thorac Oncol 2007; 2: 1086-1090.
14. Fassina A, Gazziero A, Zardo D, Corradin M, Aldighieri E, Rossi GP,. Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis. J Clin Pathol 2009; 62: 1096-1102.
15. Garcia-Olive I, Monso E, Andreo F, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations. Eur Respir J 2010; 35: 391-395.
16. Horiike A, Kimura H, Nishio K, et al. Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer. Chest 2007; 131: 1628-1634.
17. Molina-Vila MA, Bertran-Alamillo J, Reguart N, et al. A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells. J Thorac Oncol 2008; 3: 1224-1235.
18. Nicholson AG, Gonzalez D, Shah P, et al. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. J Thorac Oncol 2010; 5: 436-441.
19. Nomoto K, Tsuta K, Takano T, et al. Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis. Am J Clin Pathol 2006; 126: 608-615.
20. Savic S, Tapia C, Grilli B, et al. Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers. Br J Cancer 2008; 98: 154-160.
21. Smith GD, Chadwick BE, Willmore-Payne C, Bentz JS,. Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis. J Clin Pathol 2008; 61: 487-493.
22. Smouse JH, Cibas ES, Janne PA, Joshi VA, Zou KH, Lindeman NI,. EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer. Cancer Cytopathol 2009; 117: 67-72.
23. da Cunha Santos G, Saieg MA, Geddie W, Leighl N,. EGFR gene status in cytological samples of nonsmall cell lung carcinoma: Controversies and opportunities. Cancer Cytopathol 2011; 119: 80-91.
24. Chang YL, Wu CT, Shih JY, Lee YC,. Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers. Ann Surg Oncol 2011; 18: 543-550.
25. Gow CH, Chang YL, Hsu YC, et al. Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer. Ann Oncol 2009; 20: 696-702.
26. Li C, Sun Y, Fang Z, et al. Comprehensive analysis of epidermal growth factor receptor gene status in lung adenocarcinoma. J Thorac Oncol 2011; 6: 1016-1021.
27. Liang Z, Zhang J, Zeng X, Gao J, Wu S, Liu T,. Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas. BMC cancer 2010; 10: 376.
28. Li AR, Chitale D, Riely GJ, et al. EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression. J Mol Diagn 2008; 10: 242-248.
29. Killian JK, Walker RL, Suuriniemi M, et al. Archival fine-needle aspiration cytopathology (FNAC) samples: Untapped resource for clinical molecular profiling. J Mol Diagn 2010; 12: 739-745.
30. Kim SK, Kim DL, Han HS, et al. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagn Mol Pathol 2008; 17: 118-125.
31. Malapelle U, Bellevicine C, Russo A, Salatiello M, Palombini L, Troncone G,. KRAS testing on colo-rectal carcinoma cytological imprints. Diagn Cytopathol 2011; 39: 274-277.